Stockscreener 앱 받기
7.53
8.73%
-0.72
시간 외 거래:
7.53
전일 마감가:
$8.25
열려 있는:
$8.28
하루 거래량:
80,888
Relative Volume:
1.01
시가총액:
$40.30M
수익:
$7.97M
순이익/손실:
$-75.74M
주가수익비율:
-0.3101
EPS:
-24.2853
순현금흐름:
$-85.33M
1주 성능:
-22.93%
1개월 성능:
-25.22%
6개월 성능:
+34.46%
1년 성능:
-21.15%
1일 변동 폭
$7.4526
$8.469
1주일 범위
$7.4526
$10.06
52주 변동 폭
$3.76
$46.80
Aligos Therapeutics Inc Stock (ALGS) Company Profile
명칭
Aligos Therapeutics Inc
전화
(800) 466-6059
주소
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
ALGS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALGS
Aligos Therapeutics Inc
|
7.53 | 57.35M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-18 | 재개 | H.C. Wainwright | Buy |
| 2024-08-19 | 개시 | H.C. Wainwright | Buy |
| 2023-01-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-01-06 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-03-23 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-01-06 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-09-09 | 개시 | SVB Leerink | Outperform |
| 2021-05-17 | 재개 | Piper Sandler | Overweight |
| 2020-11-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-10 | 개시 | JP Morgan | Overweight |
| 2020-11-10 | 개시 | Jefferies | Buy |
| 2020-11-10 | 개시 | Piper Sandler | Overweight |
모두보기
Aligos Therapeutics Inc 주식(ALGS)의 최신 뉴스
Is Aligos Therapeutics Inc. (5WK0) stock resilient in recession scenarios2025 Performance Recap & Comprehensive Market Scan Insights - newser.com
Is Aligos Therapeutics Inc. (5WK0) stock safe for risk averse investors2025 Big Picture & Real-Time Price Movement Reports - newser.com
How to build a dashboard for Aligos Therapeutics Inc. stock2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com
When is the best time to exit Aligos Therapeutics Inc.Trade Entry Summary & Scalable Portfolio Growth Ideas - newser.com
How buybacks impact Aligos Therapeutics Inc. stock valueWeekly Stock Summary & High Conviction Buy Zone Picks - newser.com
Why Aligos Therapeutics Inc. stock remains on buy listsJuly 2025 Patterns & Weekly Top Stock Performers List - newser.com
How to forecast Aligos Therapeutics Inc. trends using time series2025 Breakouts & Breakdowns & Community Shared Stock Ideas - newser.com
How Aligos Therapeutics Inc. (5WK0) stock stacks up against competitors2025 Market WrapUp & Accurate Buy Signal Alerts - newser.com
Multi factor analysis applied to Aligos Therapeutics Inc.Dollar Strength & Safe Investment Capital Preservation Plans - newser.com
Is Aligos Therapeutics Inc a good long term investmentChart Pattern Recognition & Free Rapid Return Acceleration - earlytimes.in
Is Aligos Therapeutics Inc. stock positioned well for digital economy2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
Aligos Therapeutics, Inc. (ALGS) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Is Aligos Therapeutics Inc. stock supported by strong fundamentalsEarnings Overview Report & Precise Buy Zone Tips - newser.com
Published on: 2025-10-31 04:14:04 - newser.com
Is Aligos Therapeutics Inc. (5WK0) stock a fit for income portfoliosDollar Strength & Weekly Stock Performance Updates - newser.com
Can Aligos Therapeutics Inc. (5WK0) stock double in coming yearsTrade Entry Report & Safe Capital Growth Plans - newser.com
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025 - The Manila Times
Aligos Therapeutics (Nasdaq: ALGS) to announce financial results Nov 6, 2025 - Stock Titan
Aligos Therapeutics Inc (ALGS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):